Back to AZN Stock Lookup

AstraZeneca (AZN) –

Jul 29, 2015 06:43 AM Form 6-K ASTRAZENECA PLC For: Jul 29
Jul 27, 2015 09:58 AM Notable Mergers and Acquisitions 7/27: (TEVA)/(AGN) (WAB) (BECN) (SNY) (XUE)
Jul 27, 2015 07:30 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 27, 2015 07:11 AM Form 6-K ASTRAZENECA PLC For: Jul 27
Jul 27, 2015 06:45 AM Genzyme (SNY) to Acquire AstraZeneca's (AZN) Caprelsa
Jul 22, 2015 09:30 AM Pre-Open Stock Movers 07/22: (ISRG) (THOR) (EYES) Higher; (XOMA) (ILMN) (AAPL) Lower (more...)
Jul 22, 2015 06:46 AM Array BioPharma (ARRY) Declines; AstraZeneca (AZN) Says Phase 3 SUMIT Study of Selumetinib in Combination with Dacarbazine Misses Primary Endpoint
Jul 17, 2015 09:13 AM Form 6-K ASTRAZENECA PLC For: Jul 17
Jul 17, 2015 07:10 AM Form 6-K ASTRAZENECA PLC For: Jul 17
Jul 15, 2015 05:00 PM InnerWorkings (INWK) Enters Seven-Year Marketing Agreement with AstraZeneca (AZN)
Jul 14, 2015 06:28 AM Form 6-K ASTRAZENECA PLC For: Jul 14
Jul 14, 2015 06:00 AM Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City
Jul 13, 2015 07:27 PM IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 07:27 PM CORRECTING and REPLACING IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 07:27 PM CORRECTING and REPLACING IRESSA® (gefitinib) Approved by the U.S. Food and Drug Administration for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
Jul 13, 2015 03:47 PM Qiagen (QGEN) Announces Receipt of FDA PMA for Therascreen EGFR Test for Use with IRESSA in NSCLC
Jul 13, 2015 01:34 PM FDA Approves AstraZeneca's (AZN) Iressa for First-line Treatment of Patients with Type of Metastatic Lung Cancer (QGEN)
Jul 9, 2015 07:15 AM Form 6-K ASTRAZENECA PLC For: Jul 09
Jul 8, 2015 08:03 AM AstraZeneca (AZN), Ironwood (IRWD) Announce All Primary, Secondary Endpoints Met in Linaclotide Phase 3
Jul 8, 2015 08:00 AM AstraZeneca Celebrates More Than 35 Years of Ongoing Patient Support Through Its Patient Assistance Programs
Jul 2, 2015 10:54 AM Notable Analyst Rating Changes 7/2: (T) (KOS) (KIM) Upgraded; (GNRC) (BTU) (RF) Downgraded
Jul 2, 2015 08:12 AM Berenberg Upgrades AstraZeneca (AZN) to Buy
Jul 1, 2015 06:40 AM Form 6-K ASTRAZENECA PLC For: Jul 01
Jun 29, 2015 04:09 PM FibroGen (FGEN) Announces Receipt of $120M Milestone from AstraZeneca (AZN)
Jun 26, 2015 07:37 AM Form 6-K ASTRAZENECA PLC For: Jun 26
Jun 25, 2015 06:42 AM Form 6-K ASTRAZENECA PLC For: Jun 25
Jun 21, 2015 05:00 AM Lions Health Announces Winners
Jun 17, 2015 05:04 PM Receptos (RCPT) Will Be Patient on Takeover, Leerink Partners Says; Insider Sales Not a Tell
Jun 16, 2015 03:53 PM Receptos, Inc (RCPT) Price Target Raised to $348 at Wedbush; Analyst Sees Bidding War
Jun 16, 2015 09:36 AM Form 6-K ASTRAZENECA PLC For: Jun 16
Jun 13, 2015 09:00 AM AstraZeneca Announces Phase III Results for Lesinurad in Combination with Febuxostat in Tophaceous Gout Patients at European League Against Rheumatism Annual Congress (EULAR 2015)
Jun 11, 2015 10:10 AM Receptos (RCPT) Adds to Gains on Ongoing Takeover Chatter
Jun 10, 2015 10:46 AM UPDATE: AstraZeneca's (AZN) CMO to Depart for Another Opportunity
Jun 9, 2015 10:41 AM Receptos (RCPT) Bounces Off Lows on Report It Rejected $200/Share Offer
Jun 8, 2015 09:24 AM Cholesterol Awareness Initiative Makes Its Move Across America
Jun 3, 2015 12:58 PM Unusual 11 Mid-Day Movers 6/3: (BLFS) (LPTH) (ARDX) Higher; (EMITF) (ORIG) (CDTI) Lower
Jun 3, 2015 12:11 PM Form 6-K ASTRAZENECA PLC For: Jun 03
Jun 3, 2015 06:22 AM Ardelyx (ARDX), AstraZeneca (AZN) Terminate NHE3 Inhibitor Agreement; Tenapanor Rights Regained
Jun 3, 2015 06:19 AM Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds
Jun 2, 2015 01:55 PM Juno Therapeutics (JUNO) Move Off the Highs as AstraZeneca (AZN) Deal Far from Certain
Jun 2, 2015 10:26 AM AstraZeneca (AZN) Would Consider Buying Company Such as Juno (JUNO) - Bloomberg
Jun 2, 2015 09:30 AM AstraZeneca (AZN) Provides Update on Immuno-Oncology Pipeline at ASCO
Jun 2, 2015 09:27 AM AstraZeneca Updates on Immuno-Oncology Combinations Development Program at ASCO 2015
Jun 2, 2015 06:15 AM Actavis Affirms Commitment To Advancing Antibiotic Stewardship At White House Forum
Jun 1, 2015 10:14 AM Form 6-K ASTRAZENECA PLC For: Jun 01
Jun 1, 2015 10:06 AM Form 6-K ASTRAZENECA PLC For: Jun 01
May 31, 2015 09:00 AM AstraZeneca Presents Positive Data on AZD9291 in First-Line EGFR Mutated Lung Cancer at ASCO 2015
May 30, 2015 09:28 AM AstraZeneca and MedImmune Present Positive Immuno-Oncology Combination Data at ASCO 2015
May 29, 2015 09:56 AM Eli Lilly & Co. (LLY) Shares Show Strength
May 29, 2015 08:00 AM Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumors

Back to AZN Stock Lookup